Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Definitive Healthcare Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Definitive Healthcare Names Carrie Lazorchak as Chief Revenue Officer"
08/24/2023 144 Form 144 - Report of proposed sale of securities:
08/24/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2023 Second quarter revenue grew 12% year-over-year to $61.0 million Framingham, MA –"
08/14/2023 10-Q/A Quarterly Report for the period ended March 31, 2023 [amend]
08/14/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
08/01/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/01/2023 8-K Quarterly results
06/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/12/2023 144 Form 144 - Report of proposed sale of securities:
05/12/2023 144 Form 144 - Report of proposed sale of securities:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
Docs: "Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2023 First quarter revenue grew 18% year-over-year to $59.2 million Framingham, MA –"
04/20/2023 ARS Form ARS - Annual Report to Security Holders:
04/20/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/20/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
02/27/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/27/2023 10-K Annual Report for the period ended December 31, 2022
02/23/2023 8-K Quarterly results
Docs: "RE: Amendment to Executive Chairman Agreement and Employment Agreement",
"DEFINITIVE HEALTHCARE CORP. CASH INCENTIVE PLAN Effective February 16, 2023 1. Purposes of the Plan. The Plan is intended to increase stockholder value and the success of the Company by motivating Employees to perform to the best of their abilities, and achieve the Company’s objectives. 2. Definitions. “Actual Award” means, as to any Performance Period, the actual award payable to a Participant for the Performance Period, subject to the Committee’s authority under Section 3 to modify the award. “Affiliate” means any corporation or other entity controlled by the Company. “Board” means the Board of Directors of the Company. “Code” means the United States Internal Revenue Code of 1986, as amended. Reference to a specific section of the C...",
"Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2022 Fourth quarter revenue grew 31% year-over-year to $60.6 million Full year 2022 revenue grew 34% to $222.7 million Framingham, MA –"
02/14/2023 SC 13G/A SEA VII Management, LLC has filed a Schedule 13D for Definitive Healthcare Corp.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/12/2023 8-K Cost Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits &nbs...
Docs: "Email to Definitive Healthcare employees from Robert Musslewhite, (furnished herewith pursuant to Item 7.01)"
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
10/07/2022 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
10/03/2022 8-K Resignation/termination of a director
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Form of Director Restricted Stock Unit Award Agreement under 2021 Equity Incentive Plan",
"Definitive Healthcare Announces Changes to Board of Directors"
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
Docs: "Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2022"
05/26/2022 8-K Quarterly results
05/05/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/05/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/05/2022 8-K Quarterly results
Docs: "Amended and Restated Employment Agreement, by and among Definitive Healthcare, LLC, Definitive Healthcare Corp. and Robert Musslewhite",
"Executive Chairman Agreement, by and among Definitive Healthcare, LLC, Definitive Healthcare Corp. and Jason Krantz",
"Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2022",
"Definitive Healthcare Names Robert Musslewhite as CEO Effective August 1, 2022"
04/12/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy